Kyowa Hakko Kirin is Pharmaceuticals in Japan that focus on Kirin Co Ltd business. Founded in 1949. They cover business area such as Kyowa Kirin Co Ltd, biologic medicine, its operation, four category, nephrology, oncology, immunology, allergy, two reportable segment, Pharmaceuticals, Biochemicals, ethical pharmaceutical, diagnostic reagent, raw material, pharmaceutical and industrial use, mainly amino acid, nucleic acid, relate compound, healthcare product.
1949
( 75 years old in 2024 )
Kirin Co Ltd
-
Otemachi Financial City Grand Cube
1-9-2 Otemachi, Chiyoda-ku
Tokyo, 100-0004
Japan
Private
Kyowa Kirin Co Ltdbiologic medicineits operationfour categorynephrologyoncologyimmunologyallergytwo reportable segmentPharmaceuticalsBiochemicalsethical pharmaceuticaldiagnostic reagentraw materialpharmaceutical and industrial usemainly amino acidnucleic acidrelate compoundhealthcare product
* We use standard office opening hours in near Kyowa Hakko Kirin's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Kyowa Hakko Kirin is Pharmaceuticals business from Japan that founded in 1949 (75 years old in 2024), Kyowa Hakko Kirin business is focusing on Kirin Co Ltd.
Kyowa Hakko Kirin headquarter office and corporate office address is located in Otemachi Financial City Grand Cube 1-9-2 Otemachi, Chiyoda-ku Tokyo, 100-0004 Japan.
Kyowa Hakko Kirin was founded in Japan.
In 2024, Kyowa Hakko Kirin is currently focus on Kirin Co Ltd sector.
Above is snippet of Google Trends for "Kirin Co Ltd" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Kyowa Hakko Kirin, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
